Ma Ying Long Musk Hemorrhoids Ointment
NDC Package 68511-997-01
Package Information
Ma Ying Long Musk Hemorrhoids (petrolatum, zinc oxide) ointment is adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. This formulation utilizes a ointment delivery system. Marketed by Mayinglong Pharmaceutical Group Co., Ltd., this product is identified by NDC 68511-997 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 2396041 - petrolatum 77.99 % / zinc oxide 7.6 % Topical Ointment
- RxCUI: 2396041 - petrolatum 0.78 MG/MG / zinc oxide 0.076 MG/MG Topical Ointment
- RxCUI: 2396041 - petrolatum 0.78 MG/MG / ZNO 0.076 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68511 - Mayinglong Pharmaceutical Group Co., Ltd.
- 68511-997 - Ma Ying Long Musk Hemorrhoids
- 68511-997-01 - 1 TUBE in 1 BOX / 10 g in 1 TUBE
- 68511-997 - Ma Ying Long Musk Hemorrhoids
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68511-997). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68511-997-01 identifies a specific commercial package of 1 tube in 1 box / 10 g in 1 tube of Ma Ying Long Musk Hemorrhoids, a human over the counter drug labeled by Mayinglong Pharmaceutical Group Co., Ltd.. This ointment is formulated for topical use and contains petrolatum; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mayinglong Pharmaceutical Group Co., Ltd. on December 15, 2003. The current certification is valid through December 31, 2026.
How is this Mayinglong Pharmaceutical Group Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68511099701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.